The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive

REFERENCES

• Fern M, Rose D, Fern E. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol 1978;51:541–4.
   PubMed Web of Science ®Google Scholar
• Aden U, Jung-Hoffmann C, Kuhl H. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception 1998;58:75–81.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Kutschera E, Lee J, et al. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003;67:25–32.
   PubMed Web of Science ®Google Scholar
• Ågren UM, Anttila M, Mäepää-Liukko K, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17ß-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care 2011;16:458–67.
   PubMed Web of Science ®Google Scholar
• Van der Vange N, Blankenstein M, Kloosterboer H, et al. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception 1990; 41:345–52.
   PubMed Web of Science ®Google Scholar
• Coenen C, Thomas C, Borm G, et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996;53:171–6.
   PubMed Web of Science ®Google Scholar
• Greco T, Graham C, Bancroft J, et al. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35 or 25 μg of ethinyl estradiol. Contraception 2007;76:8–17.
   PubMed Web of Science ®Google Scholar
• Bachmann G, Bancroft J, Braunstein G, et al. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:660–5.
   PubMed Web of Science ®Google Scholar
• Traish A, Guay A, Spark R, the Testosterone Therapy in Women Study Group. Are the Endocrine Society's clinical practice guidelines on androgen therapy in women misguided? A commentary. J Sex Med 2007;4:1223–35.
   PubMed Web of Science ®Google Scholar
• Arlt W, Justl H-G, Callies F, et al. Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 1998;83:1928–34.
   PubMed Web of Science ®Google Scholar
• Morales A, Nolan J, Nelson J, Yen S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360–7.
   PubMed Web of Science ®Google Scholar
• Legrain S, Massien C, Lahlou N, et al. Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 2000;85:3208–17.
   PubMed Web of Science ®Google Scholar
• Meno-Tetang G, Blum R, Schwartz K, Jusko W. Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics or oral prednisone and cortisol suppression in normal women. J Clin Pharmacol 2001; 41:1195–205.
   PubMed Web of Science ®Google Scholar
• Zimmerman Y, Wouters W, Coelingh Bennink HJT. The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of DHEA. Eur J Contracept Reprod Health Care 2013;18:206–14.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84:3666–72.
   PubMed Web of Science ®Google Scholar
• de Ronde W, van der Schouw YT, Pols HAP, et al. Calculation of bioavailable and free testosterone in men: A comparison of 5 published algorithms. Clin Chem 2006;52:1777–84.
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Geay A, Déchaud H, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002; 11:1065–71.
   PubMed Web of Science ®Google Scholar
• Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: Comparison of methods. J Clin Endocrinol Metab 2004;89:525–33.
   PubMed Web of Science ®Google Scholar
• Parasrampuria J, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998;280:1565.
   PubMed Web of Science ®Google Scholar
• Baulieu E-E, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue. PNAS 2000;97:4279–84.
   PubMed Web of Science ®Google Scholar
• Odlind V, Milson I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?Acta Obstet Gynecol Scand 2002;81:482–90.
   PubMed Web of Science ®Google Scholar
• Carlström K, Karlsson R, Von Schoultz B. Diurnal rhythm and effects of oral contraceptives on serum dehydroepiandrosterone sulfate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretion. Scand J Clin Lab Invest 2002;62:361–8.
   PubMed Web of Science ®Google Scholar
• Hucklebridge F, Hussain T, Evans P, Clow A. The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 2005;30:51–7.
   PubMed Web of Science ®Google Scholar
• Matchock RL, Dorn LD, Susman EJ. Diurnal and seasonal cortisol, testosterone, and DHEA rhythms in boys and girls during puberty. Chronobiol Int 2007;24:969–90.
   PubMed Web of Science ®Google Scholar
• Madden JD, Milewich L, Parker CR Jr., et al. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate. Am J Obstet Gynecol 1978;132:380–4.
   PubMed Web of Science ®Google Scholar
• Nicolau GY, Haus E, Lakatua DJ, et al. Circadian and circannual variations on FSH, LH, testosterone, dehydroepiandrosterone-sulfate (DHEA-S) and 17-hydroxy progesterone (17 OH-Prog) in elderly men and women. Endocrinologie 1985;23:223–46.
   PubMedGoogle Scholar
• Mikulecky M, Kreze A, Putz Z, Moravcik M. Daily variation of serum cortisol, 17-hydroxyprogesterone and five androgens in healthy women. Braz J Med Biol Res 1995;28:485–90.
   PubMed Web of Science ®Google Scholar
• Hammer F, Subtil S, Lux P, et al. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies. J Clin Endocrinol Metab 2005;90:3600–5.
   PubMed Web of Science ®Google Scholar
• Murphy AA, Cropp CS, Smith BS, et al. Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women. Fertil Steril 1990;53:35–9.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Jung-Hoffmann C, Kuhl H. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception 1995;51:341–6.
   PubMed Web of Science ®Google Scholar
• Carr BR, Parker CR Jr., Madden JD, et al. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. J Clin Endocrinol Metab 1979;49:346–9.
   PubMed Web of Science ®Google Scholar
• Klove KL, Roy S, Lobo RA. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate. Contraception 1984;29: 319–24.
   PubMed Web of Science ®Google Scholar
• Dyner TS, Lang W, Geaga J, et al. An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J Acquir Immune Defic Syndr 1993;6:459–65.
   PubMed Web of Science ®Google Scholar
• Duijkers I, Klipping C, Grob P, Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17ß-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010;15:314–25.
   PubMed Web of Science ®Google Scholar
• Blode H, Wuttke W, Loock W, et al. A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers. Eur J Contracept Reprod Health Care 2000;5:256–64.
   PubMedGoogle Scholar
• Zimmerman Y, Coelingh Bennink HJT. Clinical effects of normalizing testosterone levels during oral contraception. Ferti Steril 2012;98(3,Suppl.): S198.
   Google Scholar
• van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception 1990;42:597–609.
   PubMed Web of Science ®Google Scholar
• Nair KS, Rizza RA, O’Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006;355:1647–59.
   PubMed Web of Science ®Google Scholar
• Weiss EP, Shah K, Fontana L, et al. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr 2009;89: 1459–67.
   PubMed Web of Science ®Google Scholar
• Alkatib AA, Cosma M, Elamin MB, et al. A systematic review and meta-analysis of randomized placebo- controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab 2009;94:3676–81.
   PubMed Web of Science ®Google Scholar
• Davis SR, Panjari M, Stanczyk FZ. DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 2011;96:1642–53.
   PubMed Web of Science ®Google Scholar